CoChat
Sign Up
Cited by 61Reproductive tract infections researchHIV/AIDS Research and InterventionsLGBTQ Health, Identity, and Policy

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Chlamydia, gonorrhea, and human immunodeficiency virus infection among transgender women and transgender men attending clinics that provide sexually transmitted disease services in six US cities: results from the Sexually Transmitted Disease Surveillance Network.

Open access
Pitasi, Marc A., Kerani, Roxanne P., Kohn, Robert, Murphy, Ryan D., Pathela, Preeti, Schumacher, Christina M., Tabidze, Irina, Llata, Eloisa·2019·Sexually Transmitted Diseases
DOI 10.1097/olq.0000000000000917PMC PMC11155260
Open this paper in CoChat — free account

Abstract

BACKGROUND: Transgender women and transgender men are disproportionately affected by human immunodeficiency virus (HIV) infection and may be vulnerable to other sexually transmitted diseases (STDs), but the lack of surveillance data inclusive of gender identity hinders prevention and intervention strategies. METHODS: We analyzed data from 506 transgender women (1045 total visits) and 120 transgender men (209 total visits) who attended 26 publicly funded clinics that provide STD services in 6 US cities during a 3.5-year observation period. We used clinical and laboratory data to examine the proportion of transgender women and transgender men who tested positive for urogenital and extragenital chlamydial or gonococcal infections and who self-reported or tested positive for HIV infection during the observation period. RESULTS: Of the transgender women tested, 13.1% tested positive for chlamydia and 12.6% tested positive for gonorrhea at 1 or more anatomic sites, and 14.2% were HIV-infected. Of transgender men tested, 7.7% and 10.5% tested positive for chlamydia and gonorrhea at 1 or more anatomic sites, and 8.3% were HIV-infected. Most transgender women (86.0% and 80.9%, respectively) and more than a quarter of transgender men (28.6% and 28.6%, respectively) with an extragenital chlamydial or gonococcal infection had a negative urogenital test at the same visit. CONCLUSIONS: Publicly funded clinics providing STD services are likely an important source of STD care for transgender persons. More data are needed to understand the most effective screening approaches for urogenital, rectal, and pharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae infections in transgender populations.

Overview

Integrity signals

Registry

Crossref · 10.1097/olq.0000000000000917

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 29 references

Cited by

Sorted by citations

See all 61

Related

See all

Metadata

Authors
Pitasi, M. A., Kerani, R. P., Kohn, R., Murphy, R. D., Pathela, P., Schumacher, C. M., Tabidze, I., & Llata, E.
Affiliations
  • Centers for Disease Control and Prevention (US)
  • Public Health – Seattle & King County (US)
  • San Francisco Department of Public Health (US)
  • Los Angeles County Department of Public Health (US)
  • New York City Department of Health and Mental Hygiene (US)
  • Johns Hopkins University (US)
  • Chicago Department of Public Health (US)
Corresponding author
  • Pitasi, Marc A.
  • Tabidze, Irina
  • Llata, Eloisa
ORCID
Venue
Sexually Transmitted Diseases
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2019-02
Volume
46
Issue
2
Pages
112-117
ISSN
  • 0148-5717 (ISSN-L)
  • 1537-4521
DOI
10.1097/olq.0000000000000917
PMC
PMC11155260
OpenAlex
W2894633972
Cited by
61
References
29
Citations by year
2026: 6 · 2025: 8 · 2024: 7 · 2023: 9 · 2022: 10 · 2021: 7 · 2020: 10 · 2019: 4
FWCI
4.24
Type
journal article
Language
en
Open access
Locations
  • Sexually Transmitted Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institutes of Health (CC999999)
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
  • Social Sciences › Psychology › Social Psychology › LGBTQ Health, Identity, and Policy
Keywords
transgender women, transgender men, chlamydia, gonorrhea, HIV infection, STD surveillance, STD clinics, Chlamydia trachomatis, Neisseria gonorrhoeae, extragenital infection, urogenital infections, STI screening, gender identity
MeSH terms
Adolescent, Adult, Chlamydia Infections, Cities, Female, Gonorrhea, Humans, Male, Middle Aged, Sexually Transmitted Diseases, United States, HIV Infections, Sentinel Surveillance, Young Adult, Transgender Persons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review